	Cancer Stem Cell-Targeted Therapies in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Cancer Invest Rebai O, Amri M, Fattouch S. PMID: 42615808 [PubMed - as supplied by publisher]
	Estimating lead time and overdiagnosis in cancer screening programmes: the MOCCI method. Int J Epidemiol Vratanar B, Pohar Perme M. PMID: 42615544 [PubMed - indexed for MEDLINE]
	Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy. JACC CardioOncol Gynnild MN, Lilleaasen AM, Wethal T, Jakobsen EO, Vinje-Jakobsen V, Heck SL, Larsen S, Rösner A, Dalen H, Omland T, Gulati G, Holte E. PMID: 42615453 [PubMed]
	Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer. JACC CardioOncol Moore H, Huppert LA, Moslehi JJ, Yang EH, Hatcher S, Thomas A. PMID: 42615445 [PubMed]
	Strategies for Targeting Mitochondria in the Treatment of Breast Cancer. ACS Pharmacol Transl Sci Wang K, Zheng X, Li Y, Li C, Zhang X, Deng Q, Yang H, Shuai X, Li J, Guo L, Shi J, Bai L. PMID: 42614851 [PubMed]
	Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study. Front Oncol Mazo Canola M, Schear R, Housman LT, Backus KV, Hogea C. PMID: 42614301 [PubMed]
	Faith, Culture, and Cancer: A Qualitative Study Exploring Muslim Women's Perspectives on Clinical Trials in the United Kingdom. Health Expect Turner L, Taylor S, Ward A, Ahmed N, Yorke J. PMID: 42613836 [PubMed - indexed for MEDLINE]
	Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis. J Natl Cancer Inst Massa D, Chiappe E, Delucchi V, Girardi F, Blondeaux E, La Commare M, Guarneri V, Lambertini M, Dieci MV. PMID: 42613756 [PubMed - as supplied by publisher]
	Early Prediction Of Treatment Response To Neoadjuvant Chemotherapy Based On Pre-treatment Ultrasound Radiomics of HER2-positive Breast Cancer Patients by Radiomics-based Model: A Dual-center Retrospective Study. Acad Radiol Du LW, Zha HL, Pan JZ, Du Y, Liu W, Nie CL, Liu XP, Zong M, Zhang B. PMID: 42613278 [PubMed - as supplied by publisher]
	Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER). Ann Oncol Kalinsky K, Barlow WE, Pathak HB, Puri RV, Mitra A, Home T, Gralow J, Albain KS, Hayes DF, Delaloge S, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Rastogi P, Schott AF, Brain E, Pierga JY, Ferrero JM, Shak S, Tripathy D, Hortobagyi GN, Meric-Bernstam F, Sharma P, Pusztai L, Thompson A, Godwin AK. PMID: 42613139 [PubMed - indexed for MEDLINE]
	The role of chimeric antigen receptor (CAR) T cell therapy in breast cancer. Int Immunopharmacol Farajzadeh A, Mahmoudi M, Yazdani S, Barati AM, Kheder RK, Rostami O, Fadaee A, Raouf-Rahmati A, Esmaeili SA. PMID: 42612349 [PubMed - as supplied by publisher]
	Potential small-molecule tyrosine kinase inhibitors (TKIs) for the treatment of triple-negative breast cancer (TNBC): Targets, structure-activity relationships, and clinical studies. Eur J Med Chem Yuan H, Li H, Zhou Y, He Z, Yang S, Wang L, He Y, Li L, Yu D, Shi J. PMID: 42612290 [PubMed - as supplied by publisher]
	Construction of Human Breast Cancer Organoids and Comet Assay-Based Quantification of Doxorubicin-Induced DNA Damage. J Vis Exp Wu Y, Jin Z, Du J, Li L, Ouyang W, Yin L, Zhao S, Li J, Li X, Liu SB. PMID: 42612119 [PubMed - indexed for MEDLINE]
	Comprehensive Analysis of m6A Regulators Identifies YTHDF3 as a Promising Prognostic Biomarker for Breast Cancer. J Vis Exp Jin P, Fan Y. PMID: 42612048 [PubMed - indexed for MEDLINE]
	Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev Sattayapiwat O, Weaver DL, Borowsky AD, Keegan THM, Sprague BL, Kerlikowske K, Miglioretti DL. PMID: 42611528 [PubMed - as supplied by publisher]
	Long-Term Fatigue After Treatment for Breast Cancer. JAMA Netw Open Avis NE, O'Connell NS, Mihalko SL, Jordan JH, Ladd AC, Lesser GJ, Olson KC, Weaver KE, Dressler EV, Grizzard PJ, Levine B, Moore TL, Ky B, Hackney MH, Brubaker P, Reding KW, Lucas AR, Bellissimo MP, Moeller FG, Kitzman DW, Hamilton CA, Klepin HD, Yeboah J, Ntim W, Zaha VG, D'Agostino R Jr, Hundley WG. PMID: 42611514 [PubMed - indexed for MEDLINE]
	Preoperative MRI versus Ultrasound in Axillary Nodal Staging in Breast Cancer: Additive Role of MRI. J Breast Imaging Arjmandi FK, Ozcan BB, Hu T, Froix A, McArthur H, Xi Y, Dogan BE. PMID: 42611512 [PubMed - as supplied by publisher]
	THBS2: the key hub linking breast cancer stroma, immunity, and therapeutic response. Clin Exp Metastasis Wan X, Zhao X, Lin Y, Yang S, Dai H, Li Y, Wang X. PMID: 42611356 [PubMed - indexed for MEDLINE]
	Factors influencing decision regret regarding contralateral prophylactic mastectomy in women at high risk of hereditary breast cancer: a cross-sectional study. Support Care Cancer Park SY, Kim Y. PMID: 42611345 [PubMed - indexed for MEDLINE]
	Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research. Nanomedicine (Lond) Zahraie N, Chivu A, MacRobert AJ, Patra H, Yaghini E. PMID: 42610677 [PubMed - as supplied by publisher]

Articles 1 - 20 / 221232

Page 1 of 11062



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy